Biolegend, 101903, PE anti-mouse CD25 Antibody, 25μg

CD25 is a 55 kD glycoprotein, also known as the low affinity IL-2Rα, Ly-43, p55, or Tac. It is expressed on activated T and B cells, thymocyte subset, pre-B cells, and T regulatory cells. In association with CD122 (IL-2Rβ) and CD132(common γ chain), CD25 forms the high affinity signaling IL-2 receptor.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: IL-2-dependent BALB/c mouse helper T-cell clone HT-2
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Additional reported applications (for the relevant formats) include: in vitro blocking of IL-2 binding to low- and high-affinity receptors1,2, and immunohistochemical staining of acetone-fixed frozen sections. 3C7 antibody recognizes different epitope of PC61 antibody (Cat. No. 102002). The Ultra-LEAF™Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 101925 and 101926).
Application References(PubMed link indicates BioLegend citation): Ortega RG, et al. 1984. J. Immunol. 133:1970. (Block) Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
Product Citations: Jayachandran R, et al. 2019. Immunity. 50:152. PubMed Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed Sugiura A, et al. 2022. Immunity. 55:65. PubMed Kim HI, et al. 2022. Molecules. 27: . PubMed Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed Benhamou D, et al. 2018. Front Immunol. 2.260416667. PubMed Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed Lian G et al. 2018. eLife. 7 pii: e36158. PubMed LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed Roy S, et al. 2020. Sci Rep. 10:10992. PubMed Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed Sehnert B, et al. 2022. Front Immunol. 13:921488. PubMed Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed Perry JSA, et al. 2018. Immunity. 48:923. PubMed Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed Chen C, et al. 2019. Cell Rep. 29:4200. PubMed An J, et al. 2022. iScience. 25:103570. PubMed Sidwell T, et al. 2020. Nat Commun. 0.633333333. PubMed Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed Xu X, et al. 2018. J Dermatol Sci. 91:134. PubMed Kyburz A, et al. 2017. Clin Exp Allergy. 47:1331. PubMed Toro Acevedo CA, et al. 2017. Front Microbiol. 8:2188. PubMed Lou Y, et al. 2021. Int J Mol Sci. 22:. PubMed Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed Haque A, et al. 2020. Exp Neurol. 330:113315. PubMed von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed Roy S, et al. 2021. Nat Commun. 12:3182. PubMed Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed Rui J, et al. 2021. Nat Commun. 12:5074. PubMed Kim S, et al. 2022. Cancers (Basel). 14:. PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Chen S, et al. 2018. Nat Commun. 9:5298. PubMed Terlizzi M, et al. 2021. Cell Physiol Biochem. 55:539. PubMed
RRID: AB_312846 (BioLegend Cat. No. 101903) AB_312847 (BioLegend Cat. No. 101904)
Structure: Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
Distribution: Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells
Function: IL-2 receptor, signal transduction
Ligand/Receptor: IL-2
Cell Type: B cells, T cells, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules, Cytokine/Chemokine Receptors
Antigen References: 1. Taniguchi T, et al. 1993. Cell 73:5. 2. Waldmann TA. 1991. J. Biol. Chem. 266:2681. 3. Read S, et al. 2000. J. Exp. Med. 192:295. 4. Lowenthal JW, et al. 1985. J. Immunol. 135:3988.
Gene ID: 16184
UniProt: View information about CD25 on UniProt.org
Clone: 3C7
Regulatory Status: RUO
Other Names: IL-2Rα, Ly-43, p55, Tac
Isotype: Rat IgG2b, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.